Merrill Lynch & Co. bankers Alan Hartman, Richard Girling and Mark Robinson joined Centerview Partners LLC to build its healthcare practice. The firm is also opening offices in London and San Francisco.
Hartman was Merrill's head of Americas mergers and acquisitions and global head of healthcare M&A, and Girling and Robinson were global co-heads of Merrill's healthcare investment banking group.
Hartman will work from New York, while Girling and Robinson will be senior partners in the London and San Francisco offices, respectively. Hartman joined Merrill in 1993; Girling and Robinson joined in 1998.
Following Merrill's acquisition by Bank of America Corp., Hartman was appointed head of Americas M&A for the combined organization, Girling was named head of the merged Europe, Middle East and Asia and Asia-Pacific healthcare practices and Robinson became co-head of Americas healthcare investment banking.
Collectively, the trio has worked on deals including Pfizer Inc.'s $68 billion planned acquisition of Wyeth, Sanofi-Synthelabo's $63 billion acquisition of Aventis, the $25 billion leveraged buyout of Alliance Boots plc, AstraZeneca plc's $15 billion acquisition of MedImmune, Idec Pharmaceuticals' $6 billion merger with Biogen and Boston Scientific Corp.'s $25 billion acquisition of Guidant Corp.
Khaled Fathallah joined Deutsche Bank AG as co-head of metals and mining for Europe, the Middle East and Africa alongside current EMEA head Nick Taylor.
Fathallah was EMEA's head of metals and mining at Bank of America Merrill Lynch. He joined Merrill Lynch & Co. in Toronto in 1998.
Credit Suisse Group hired Takeshi Hasebe as head of its equity capital markets department in Japan.
Hasebe joins Credit Suisse from Merrill Lynch & Co., where he was most recently head of equity capital solutions in Japan. He began his career at Merrill in 1991. He moved to Deutsche Bank AG in 1996 and after working in a few senior capital markets positions, rejoined Merrill in 2004.
Check The Deal Pipeline for updates on these Movers & shakers: